Saturna Capital’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Saturna Capital’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-12,300	Closed	-$531K	–	407
2015 Q3	$531K	Buy	+12,300	New	+$519K	0.02%	153
2015 Q2	–	Sell	-13,657	Closed	-$530K	–	370
2015 Q1	$530K	Hold	13,657	–	–	0.01%	153
2014 Q4	$460K	Buy	+13,657	New	+$482K	0.01%	167

Other funds holding WX

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CCS

Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Saturna Capital's WX Position: Q4 2015 in Review

Saturna Capital sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 12,300 shares — an estimated $531K sold.

Saturna Capital first reported a position in WX in Q4 2014 and held it in 3 quarters. The position peaked at $531K in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

Saturna Capital reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
Saturna Capital sold 12,300 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $531K.
Saturna Capital first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q4 2014 and held it in 3 quarters.
Saturna Capital's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $531K in Q3 2015.
2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Saturna Capital's 13F filing for Q4 2015, filed 12 Feb 2016.